GB2187191A - Protection of proteins and the like - Google Patents

Protection of proteins and the like

Info

Publication number
GB2187191A
GB2187191A GB08704890A GB8704890A GB2187191A GB 2187191 A GB2187191 A GB 2187191A GB 08704890 A GB08704890 A GB 08704890A GB 8704890 A GB8704890 A GB 8704890A GB 2187191 A GB2187191 A GB 2187191A
Authority
GB
United Kingdom
Prior art keywords
proteins
trehalose
protection
macromolecules
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08704890A
Other versions
GB8704890D0 (en
GB2187191B (en
Inventor
Bruce Joseph Roser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Bioresources Ltd
Original Assignee
Quadrant Bioresources Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2187191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858517352A external-priority patent/GB8517352D0/en
Priority claimed from GB868613066A external-priority patent/GB8613066D0/en
Application filed by Quadrant Bioresources Ltd filed Critical Quadrant Bioresources Ltd
Priority to GB8704890A priority Critical patent/GB2187191B/en
Priority claimed from PCT/GB1986/000396 external-priority patent/WO1987000196A1/en
Publication of GB8704890D0 publication Critical patent/GB8704890D0/en
Publication of GB2187191A publication Critical patent/GB2187191A/en
Application granted granted Critical
Publication of GB2187191B publication Critical patent/GB2187191B/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2002/065—Y-shaped blood vessels

Abstract

Sensitive proteins and other macromolecules, such as enzymes, antibodies, antigens, serum complement, fluorescent proteins, vaccine components, polysaccharides such as agarose etc., can be preserved by drying at ambient temperature and at atmospheric pressure in the presence of trehalose. A porous matrix impregnated with trehalose is provided as a receiver for a blood or other liquid sample to be dried.
GB8704890A 1984-01-30 1986-07-09 Protection of proteins and the like Expired GB2187191B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8704890A GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57509184A 1984-01-30 1984-01-30
GB858517352A GB8517352D0 (en) 1985-07-09 1985-07-09 Protection of proteins
GB868613066A GB8613066D0 (en) 1986-05-29 1986-05-29 Protection of proteins &c
GB8704890A GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like
PCT/GB1986/000396 WO1987000196A1 (en) 1985-07-09 1986-07-09 Protection of proteins and the like

Publications (3)

Publication Number Publication Date
GB8704890D0 GB8704890D0 (en) 1987-04-08
GB2187191A true GB2187191A (en) 1987-09-03
GB2187191B GB2187191B (en) 1989-11-01

Family

ID=27449677

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8704890A Expired GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like

Country Status (1)

Country Link
GB (1) GB2187191B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
US6620791B1 (en) 1999-05-20 2003-09-16 British Sugar Plc Edible compositions containing trehalose
WO2013110956A1 (en) 2012-01-27 2013-08-01 Stablepharma Ltd Improved injections

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1855591A (en) * 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
FR2406999A1 (en) * 1977-10-27 1979-05-25 Behringwerke Ag STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
FR2532178A1 (en) * 1982-08-31 1984-03-02 Asahi Chemical Ind PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME
EP0111216A2 (en) * 1980-03-31 1984-06-20 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
EP0140489A1 (en) * 1983-08-05 1985-05-08 Wako Pure Chemical Industries, Ltd. Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1855591A (en) * 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
FR2406999A1 (en) * 1977-10-27 1979-05-25 Behringwerke Ag STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES
GB2009198A (en) * 1977-10-27 1979-06-13 Behringwerke Ag Stabilized polysaccharides
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
EP0111216A2 (en) * 1980-03-31 1984-06-20 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
FR2532178A1 (en) * 1982-08-31 1984-03-02 Asahi Chemical Ind PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME
GB2126588A (en) * 1982-08-31 1984-03-28 Asahi Chemical Ind A method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing the same
EP0140489A1 (en) * 1983-08-05 1985-05-08 Wako Pure Chemical Industries, Ltd. Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JP A 60149972 *
PATENTS ABSTRACTS OF JAPAN, VOLUME 9, NO. 323 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
US6620791B1 (en) 1999-05-20 2003-09-16 British Sugar Plc Edible compositions containing trehalose
WO2013110956A1 (en) 2012-01-27 2013-08-01 Stablepharma Ltd Improved injections
US10821210B2 (en) 2012-01-27 2020-11-03 Stablepharma Ltd Injections

Also Published As

Publication number Publication date
GB8704890D0 (en) 1987-04-08
GB2187191B (en) 1989-11-01

Similar Documents

Publication Publication Date Title
DK120787A (en) PROTECTION OF PROTEINS AND LIKE
DK97189A (en) immobilization
MX9804086A (en) Article for collecting and transporting a sample to be analyzed and procedure for determining an analyte.
FI863738A0 (en) Censor
DK0480109T3 (en) Tubes or small straws for cryogenic storage of biological samples, such as viruses, and methods for loading them
DK96689A (en) IMMUNE DETERMINATION AND DIAGNOSTIC METHOD FOR USING THE PROCEDURE
EP0184417A3 (en) Apparatus and method for cryopreparing biological tissue for ultrastructural analysis
GB2187191A (en) Protection of proteins and the like
SE8502574D0 (en) PROCEDURE FOR CROSS-BINDING OF A POROS POLYSACKARIDGEL
NO162535C (en) DEVICE FOR EXTRACTION AND CONDITIONING OF SAMPLES OF MATERIALS IN SOLID, LIQUID OR GAS FORMS FOR ANALYSIS THEREOF.
SE7903821L (en) KINETICAL SATURATION OF THE GLYCOSE CONCENTRATION IN BODY WELDING AND PREPARATION
CA992857A (en) Reagent formulations for assaying biological specimens and methods of preparing and using same
ES2037032T3 (en) PROCEDURE TO DETECT AN ANALYTE AS WELL AS AN APPROPRIATE AGENT FOR IT.
SE8206292L (en) DEVICE FOR QUANTITATIVE ELUTION OF PROTEIN OR POLYPEPTIDES OF A GEL
SE8405213L (en) DEVICE FOR TAKING UNSTORTABLE AND PRESSURE WATER (AND GAS) SAMPLES IN OPEN SYSTEM
ES369558A1 (en) Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses
SE8002595L (en) PROCEDURE FOR QUANTITATIVE DETERMINATION OF INTERFERONES AND MEANS FOR IMPLEMENTATION OF THE PROCEDURE
NO163077C (en) DEVICE FOR PYROLYSE OF SOLID OR LIQUID SAMPLES IN SMALL QUANTITIES.
NO993701L (en) Procedure for improving the visibility of fish pellets
FR2435715A1 (en) Solid-phase immunological conjugates - comprising active substance coupled to frosted glass
Tait et al. The adenylate cyclase-activating activity of cholera toxin is not associated with a nicotinamide--adenine dinucleotide glycohydrolase activity.
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
NO902603D0 (en) REGULATION OF CHARACTERISTIC BIOLOGICAL PROPERTIES IN A MATERIAL.
Ulezlo et al. Purification of glucosoisomerase from Lactobacillus brevis and its physico-chemical properties
NZ190470A (en) Purified cancer-associated protein (cadet) and antibodies directed against cadet

Legal Events

Date Code Title Description
708B Proceeding under section 8(1) patents act 1977
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
775O Application for amendment (sect. 75/1977) open to opposition
775L Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977)
775L Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977)
SP Amendment (slips) printed
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20060708